[Perspectives of pediatric liver and kidney transplantation in Japan]

Yukihiro Inomata1

  • 1Department of Pediatric Surgery and Transplantation, Kumamoto University Hospital.

Insights

Pediatric living donor transplants in Japan show high success rates for both liver (84.4% 5-year survival) and kidney (79.4% 10-year graft survival), enabling transplantation in very young children.

Area of Science:

  • Organ transplantation
  • Pediatric surgery
  • Medical innovation

Context:

  • Japan performs approximately 130 pediatric living donor liver transplants (LDLT) annually, with cadaveric transplants being rare (11 in 10 years).
  • Pediatric kidney transplantations in Japan involved 70 cases in 2008, with a majority from living donors (59 vs. 11 cadaveric).
  • Transplantations are now feasible for newborns weighing as little as 2.5 kg (liver) and children weighing 7-8 kg (kidney).

Purpose:

  • To review the current status and outcomes of pediatric living donor organ transplantation in Japan.
  • To highlight the advancements in surgical techniques and patient selection criteria.
  • To discuss the potential for increased preemptive renal transplantation in pediatric cases.

Summary:

  • Pediatric LDLT in Japan demonstrates an 84.4% five-year patient survival rate.
  • Pediatric kidney transplantations show improving graft survival, with 79.4% for cases performed after 1992.
  • Living donor kidney transplantation is technically possible for children as small as 7-8 kg.

Impact:

  • Successful pediatric living donor transplantation is expanding indications to include very small infants and children.
  • The high success rates are driving discussions to increase preemptive kidney transplantation in Japan.
  • These advancements offer improved long-term outcomes for pediatric patients requiring organ replacement.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...